Unknown

Dataset Information

0

FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway.


ABSTRACT: To better understand the signaling properties of oncogenic FGFR3, we performed phospho-proteomics studies to identify potential downstream signaling effectors that are tyrosine phosphorylated in hematopoietic cells expressing constitutively activated leukemogenic FGFR3 mutants. We found that FGFR3 directly tyrosine phosphorylates the serine/threonine kinase p90RSK2 at Y529, which consequently regulates RSK2 activation by facilitating inactive ERK binding to RSK2 that is required for ERK-dependent phosphorylation and activation of RSK2. Moreover, inhibition of RSK2 by siRNA or a specific RSK inhibitor fmk effectively induced apoptosis in FGFR3-expressing human t(4;14)-positive myeloma cells. Our findings suggest that FGFR3 mediates hematopoietic transformation by activating RSK2 in a two-step fashion, promoting both the ERK-RSK2 interaction and subsequent phosphorylation of RSK2 by ERK.

SUBMITTER: Kang S 

PROVIDER: S-EPMC2424114 | biostudies-literature | 2007 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

FGFR3 activates RSK2 to mediate hematopoietic transformation through tyrosine phosphorylation of RSK2 and activation of the MEK/ERK pathway.

Kang Sumin S   Dong Shaozhong S   Gu Ting-Lei TL   Guo Ailan A   Cohen Michael S MS   Lonial Sagar S   Khoury Hanna Jean HJ   Fabbro Doriano D   Gilliland D Gary DG   Bergsagel P Leif PL   Taunton Jack J   Polakiewicz Roberto D RD   Chen Jing J  

Cancer cell 20070901 3


To better understand the signaling properties of oncogenic FGFR3, we performed phospho-proteomics studies to identify potential downstream signaling effectors that are tyrosine phosphorylated in hematopoietic cells expressing constitutively activated leukemogenic FGFR3 mutants. We found that FGFR3 directly tyrosine phosphorylates the serine/threonine kinase p90RSK2 at Y529, which consequently regulates RSK2 activation by facilitating inactive ERK binding to RSK2 that is required for ERK-dependen  ...[more]

Similar Datasets

| S-EPMC7194644 | biostudies-literature
| S-EPMC1994119 | biostudies-literature
| S-EPMC3982206 | biostudies-literature
| S-EPMC3823124 | biostudies-literature
| S-EPMC7872905 | biostudies-literature
| S-EPMC7689462 | biostudies-literature
| S-EPMC3973739 | biostudies-literature
| S-EPMC6023753 | biostudies-literature
| S-EPMC6397164 | biostudies-literature
| S-EPMC5308578 | biostudies-literature